Exlites eyes more medtech deals from China, Taiwan, Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge m...Read more

NZ value-added dairy product launches in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

Singapore: New Zealand-based dairy biotechnology company, Quantec, announced that it has signed a distribution and suppl...Read more

Otsuka schizophrenia relapse gets FDA nod

Japan |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 01 Mar, 2013

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...Read more

US FDA issues API bulk & tapped density guidance

Japan |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 11 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...Read more

Dezima in-licenses CETP inhibitor from Mitsubishi

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jan, 2013

Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licen...Read more

South Korea approves Halaven for breast cancer

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to...Read more

Takeda's foreign recruitments suffer hostility

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2014

Singapore: The former executives and shareholders of Takeda, a leading Japanese firm, have expressed their resentment ov...Read more

Orexo re-submits NDA for cancer pain killer in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Swedish specialty pharmaceutical company, Orexo, revealed that that its partner Kyowa Hakko Kirin submitted ...Read more

Eisai reveals phase III results of breast cancer drug Halaven

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...Read more

Daiichi faces $100 mn law suit for gender discrimination

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Feb, 2013

Singapore: Six current and former female pharmaceutical sales professionals working with Daiichi Sankyo, US, have filed ...Read more

Takeda to acquire Envoy Therapeutics

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

Singapore: Takeda Pharmaceutical's wholly-owned subsidiary, Takeda America, and Envoy Therapeutics have entered into a ...Read more

Takeda drug gets positive CHMP opinion

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...Read more

Abbott, Eisai receive approval to market Humira

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

Singapore: Abbott Japan and Eisai have received approval from Japan's Ministry of Health, Labor and Welfare to market Hu...Read more

Daiichi develops antibody to prevent fracture

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...Read more

Japan approves NDA for hyperlipidemia drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

Singapore: The Japanese Ministry of Health, Labor and Welfare has approved a new drug application (NDA) of Lotriga granu...Read more

Shionogi-ViiV Healthcare announces trial results of dolutegravir

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

Singapore: Initial results received from the phase III SINGLE (ING114467) study of Shionogi-ViiV Healthcare's investigat...Read more

What is the revenue size, range of CROs in APAC?

Japan |  Analysis | By BioSpectrum Bureau  | 2 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more

FIPB clears seven pharma proposals, defers three

Japan |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 08 Jul, 2013

Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...Read more